|Articles|July 1, 2015
The Transition from Paper Records to Electonic Batch Records
Dennis Brandl, President, at BR&L Consulting, spoke with Pharmaceutical Technology about what should be expected when transitioning from paper to EBR.
Advertisement
Dennis Brandl, President, at BR&L Consulting, spoke with Pharmaceutical Technology about what should be expected when transitioning from paper to EBR.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
2
Optimizing Pharmaceutical Manufacturing Efficiency
3
European Parliament Revamps Pharmaceutical Policy Framework
4
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
5
